- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07463690
Construction and Evaluation of a Flipped Discharge Model for Stomates With Colorectal Cancer
March 5, 2026 updated by: Luo BaoJia, Sun Yat-sen University
Construction and Empirical Study of a "Flipped" Discharge Model for Colorectal Cancer Patients With Stoma Based on Response Transformation Theory Research
This multicenter randomized controlled trial aims to develop and evaluate the effectiveness of a "Flipped Discharge" intervention for colorectal cancer patients with a new intestinal stoma.
Guided by the Response to Transition Theory, the model addresses the care gap during the vulnerable post-discharge period by shifting critical support from the hospital to the patient's home.
Approximately 200 eligible patients will be randomized into either the intervention or standard care control group.
The core "Flipped Discharge" intervention occurs on the third day post-discharge, delivered either as an in-home visit by a specialist stoma nurse (via an "Internet + Nursing Service" platform) or as an intensive, standardized video follow-up with mailed instructional materials.
The study's primary outcome is the incidence of stoma-related complications.
Secondary outcomes include quality of life, self-care ability, self-efficacy, stoma adaptation, discharge readiness, healthcare costs, and satisfaction.
The trial will also explore the mechanisms by which the intervention affects patient outcomes, ultimately seeking to provide evidence for a feasible, patient-centered model to improve care continuity.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
This study aims to develop and test a "Flipped Discharge" model for colorectal cancer patients with an intestinal stoma (ostomy) based on the Response to Transition Theory.
After stoma surgery, patients often face significant physical, psychological, and social challenges during the vulnerable early post-discharge period.
Current care models, characterized by shorter hospital stays and limited follow-up support, may leave patients unprepared for self-care, potentially leading to complications, reduced quality of life, and increased hospital readmissions.
The proposed "Flipped Discharge" model shifts essential post-discharge assessments and education from the hospital to the patient's home or via enhanced remote support, aiming to provide continuous, specialized care during this critical transition.
In this multi-center study, approximately 200 eligible patients will be randomly assigned to either an intervention group receiving the "Flipped Discharge" protocol or a control group receiving standard care.
The intervention includes early telephone follow-ups and a core intervention around the third day after discharge, delivered either through an in-home visit by a specialized stoma nurse within an established "Internet + Nursing Service" network or a standardized intensive video follow-up with mailed instructional materials for patients outside the service coverage area.
The study will measure outcomes including stoma-related complications (primary outcome), patient quality of life, self-care ability, self-efficacy, adaptation to the stoma, readiness for discharge, healthcare costs, and satisfaction.
The research also seeks to understand how factors like self-efficacy influence quality of life, with the ultimate goal of determining if this model is effective and feasible in improving care continuity and patient outcomes, thereby providing evidence for a new patient-centered care model suited to the current healthcare context.
Study Type
Interventional
Enrollment (Estimated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Luo Baojia
- Phone Number: 15989044977
- Email: luobj@sysucc.org.cn
Study Locations
-
-
Guangdong
-
Guangzhou, Guangdong, China
- Sun yat-sen University Cancer Center
-
Contact:
- Luo Baojia
- Phone Number: 15989044977
- Email: luobj@sysucc.org.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Pathologically diagnosed colorectal cancer patients undergoing their first radical surgery with either abdominoperineal resection (Miles) plus permanent colostomy or sphincter-preserving anterior resection (Dixon) plus temporary ileostomy.
- Aged 18 years or older.
- Possess at least elementary school education and are able to read, communicate, and understand questionnaire content. Voluntarily participate and provide written informed consent.
- Postoperative condition is stable without major complications, and patient is conscious.
- Meets standard hospital discharge criteria with normally functioning stoma.
Exclusion Criteria:
- History of psychiatric disorders or severe cognitive impairment.
- Diagnosis with other concurrent malignancies.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Flipped Discharge Model Group
Participants receive the "Flipped Discharge" intervention based on Response to Transition Theory.
This includes standardized post-discharge telephone follow-ups on days 1-2.
The core intervention occurs around day 3 (±1 day), delivered either via an in-home visit by a certified stoma nurse through the hospital's "Internet + Nursing Service" platform or, for eligible patients outside the service area, a standardized intensive video follow-up (≥30 min) with a mailed stoma care kit.
Additional telephone support is provided at 1 week.
All interventions follow a central protocol and are conducted by trained, certified stoma care specialists.
|
This is a structured, multi-component continuing care intervention initiated after hospital discharge for colorectal cancer patients with an intestinal stoma.
Based on the Response to Transition Theory, it aims to support patients' adaptation during the critical early post-discharge period.
The core intervention is a standardized assessment and education session conducted around the third day post-discharge.
This is delivered flexibly based on patient location: either an in-home visit by a certified enterostomal therapist via a hospital-approved "Internet + Nursing Service" platform, or a standardized, intensive video follow-up (≥30 minutes) coupled with a mailed stoma care kit for those outside the service area.
The intervention is complemented by protocol-driven telephone follow-ups on days 1-2 and at 1 week to reinforce education, provide psychological support, and address individual concerns.
|
|
No Intervention: Standard Care Group
Participants receive routine post-discharge care and follow-up as per the current standard practice at their respective hospital centers.
This typically includes conventional discharge education and scheduled follow-up contacts (e.g., phone calls) conducted by hospital staff according to local protocols, without the structured, early in-home or intensive video intervention provided to the intervention group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of stoma and peristomal skin complications
Time Frame: From the initiation of the intervention (post-discharge) up to 1 month postoperatively, or as defined by the primary study endpoint period.
|
The occurrence of complications related to the intestinal stoma and the surrounding skin will be assessed using a standardized Stoma Complication Assessment Form.
This form evaluates six major items: changes in peristomal skin, degree of stoma prolapse, presence of parastomal hernia, degree of stoma stenosis, degree of stoma retraction, and degree of stoma mucocutaneous separation.
Each item has specific criteria and a scoring system, with a higher total score indicating a greater number and severity of complications.
|
From the initiation of the intervention (post-discharge) up to 1 month postoperatively, or as defined by the primary study endpoint period.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Level of adaptation to the stoma
Time Frame: From the initiation of the intervention (post-discharge) up to 1 month postoperatively, or as defined by the primary study endpoint period.
|
Measured using the Chinese version of the Ostomy Adjustment Scale (OAS) .
The scale consists of 34 items rated on a 6-point Likert scale, with total scores ranging from 34 to 204.
A higher total score indicates better psychological and social adaptation to living with a stoma.
|
From the initiation of the intervention (post-discharge) up to 1 month postoperatively, or as defined by the primary study endpoint period.
|
|
Level of stoma-related self-efficacy
Time Frame: From the initiation of the intervention (post-discharge) up to 1 month postoperatively, or as defined by the primary study endpoint period.
|
Measured using the Chinese version of the Stoma Self-Efficacy Scale (SSES) .
This 22-item scale assesses patients' confidence in managing their stoma (stoma efficacy) and in social situations (social self-efficacy) using a 5-point Likert scale.
Total scores range from 22 to 110.
A higher score indicates greater self-efficacy.
|
From the initiation of the intervention (post-discharge) up to 1 month postoperatively, or as defined by the primary study endpoint period.
|
|
Readiness for hospital discharge
Time Frame: Assessed at the core intervention point (approximately 3 days post-discharge).
|
Measured using the Chinese version of the Readiness for Hospital Discharge Scale (RHDS) .
This 12-item scale assesses a patient's self-perceived preparedness for discharge across three dimensions: personal status, coping ability, and expected support.
Each item is scored on a 0-10 scale, with total scores ranging from 0 to 120.
A higher total score indicates better readiness for discharge.
|
Assessed at the core intervention point (approximately 3 days post-discharge).
|
|
Disease-specific quality of life
Time Frame: From the initiation of the intervention (post-discharge) up to 1 month postoperatively, or as defined by the primary study endpoint period.
|
Measured using the Chinese version of the Stoma Quality of Life Scale (Stoma-QOL-C) .
This 20-item scale evaluates the impact of the stoma on various life domains over the past month across four dimensions (e.g., sleep, social relationships).
Each item is scored on a 4-point Likert scale (1 = always, 4 = never), with total scores ranging from 20 to 80.
A higher total score indicates better stoma-specific quality of life.
|
From the initiation of the intervention (post-discharge) up to 1 month postoperatively, or as defined by the primary study endpoint period.
|
|
Self-care ability for stoma management
Time Frame: From the initiation of the intervention (post-discharge) up to 1 month postoperatively, or as defined by the primary study endpoint period.
|
Measured using the Chinese version of the Stoma Self-Care Scale - Early Stage version (SSCS-early) .
This 10-item scale specifically assesses a patient's skill in independently changing the stoma appliance.
Each item is scored on a 5-point Likert scale (1 = very unskilled, 5 = very skilled), with total scores ranging from 10 to 50.
A higher score indicates greater self-care ability.
|
From the initiation of the intervention (post-discharge) up to 1 month postoperatively, or as defined by the primary study endpoint period.
|
|
Length of Hospital Stay
Time Frame: From hospital admission for the index surgery through the follow-up period (e.g., 1 month postoperatively).
|
Measured as the average length of the index hospital admission in days.
|
From hospital admission for the index surgery through the follow-up period (e.g., 1 month postoperatively).
|
|
Healthcare Costs
Time Frame: From hospital admission for the index surgery through the follow-up period (e.g., 1 month postoperatively).
|
Includes total medical costs during the study period, covering Western and traditional Chinese medicine, stoma center fees, and supplies.
Measured in RMB.
|
From hospital admission for the index surgery through the follow-up period (e.g., 1 month postoperatively).
|
|
Intervention Implementation Costs
Time Frame: From hospital admission for the index surgery through the follow-up period (e.g., 1 month postoperatively).
|
The direct costs of implementing the "Flipped Discharge" intervention (e.g., provider travel expenses, personnel time) will be quantified separately.
Measured in RMB.
|
From hospital admission for the index surgery through the follow-up period (e.g., 1 month postoperatively).
|
|
Hospital Readmission Rate
Time Frame: From hospital admission for the index surgery through the follow-up period (e.g., 1 month postoperatively).
|
The rate of hospital readmission during the follow-up period.
Measured as a percentage (%) .
|
From hospital admission for the index surgery through the follow-up period (e.g., 1 month postoperatively).
|
|
Patient Trust and Perceived Support
Time Frame: From the initiation of the intervention (post-discharge) up to 1 month postoperatively, or as defined by the primary study endpoint period.
|
Assessed using a self-developed questionnaire evaluating the nurse-patient relationship.
The tool includes two subscales: Trust subscale: Scores range from X to Y, with higher scores indicating greater patient trust in the nurse-patient relationship.
Support subscale: Scores range from X to Y, with higher scores indicating greater perceived support from the stoma nurse.
Each item is rated on a Likert scale (e.g., 1 = not at all to 5 = completely), and subscale scores are calculated by summing the individual item scores.
|
From the initiation of the intervention (post-discharge) up to 1 month postoperatively, or as defined by the primary study endpoint period.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
March 10, 2026
Primary Completion (Estimated)
December 30, 2027
Study Completion (Estimated)
December 30, 2027
Study Registration Dates
First Submitted
December 29, 2025
First Submitted That Met QC Criteria
March 5, 2026
First Posted (Actual)
March 11, 2026
Study Record Updates
Last Update Posted (Actual)
March 11, 2026
Last Update Submitted That Met QC Criteria
March 5, 2026
Last Verified
December 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- G2025-208-01
- A2025001 (Other Grant/Funding Number: Guangdong Provincial Health Commission)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Cancer
-
University of California, San FranciscoCompletedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRectal Cancer | Colon Cancer | Cancer Survivor | Colorectal Adenocarcinoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingColorectal Adenocarcinoma | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Thomas...United States Department of DefenseActive, not recruitingColorectal Adenoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage 0 Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedCancer Survivor | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal Cancer AJCC v8 | Stage IIB Colorectal... and other conditionsUnited States
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI); National Institutes of...CompletedColorectal Cancer Metastatic | Colorectal Adenocarcinoma | Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer | Refractory Colorectal Carcinoma | Metastatic Microsatellite Stable Colorectal Carcinoma | Stage IVC Colorectal CancerUnited States
-
University of Roma La SapienzaCompletedColorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Cancer Stage 0 | Colorectal Cancer Stage IItaly
-
University of Southern CaliforniaNational Cancer Institute (NCI); AmgenTerminatedStage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Colorectal Adenocarcinoma | RAS Wild Type | Stage III Colorectal Cancer AJCC v7 | Stage IIIA Colorectal Cancer AJCC v7 | Stage IIIB Colorectal Cancer AJCC v7 | Stage IIIC Colorectal Cancer...United States
Clinical Trials on Response to Transition Theory-based Flipped Discharge Model
-
Hitit UniversityErol Olcok Corum Training and Research HospitalCompletedHysterectomy (MeSH nr: E04.950.300.399) | Had Undergone a Hysterectomy | Had Not Been Diagnosed With Cancer | After HysterectomyTurkey (Türkiye)
-
Beijing Tiantan HospitalRecruiting
-
Centers for Disease Control and PreventionColorado Department of Public Health and Environment; San Francisco Department... and other collaboratorsCompletedSexually Transmitted Diseases | HIV